A study conducted by Aston University researchers has demonstrated that the appearance of aging skin looks noticeably different compared to younger skin, when examined under polarized laser light.
FDA approves MSD’s KEYTRUDA regimen for MPM treatment
The combination of MSD’s KEYTRUDA and chemotherapy led to a statistically significant improvement in overall survival. Credit: ArDanMe/Shutterstock. The US Food and Drug Administration (FDA)